Rockwell Medical, Inc.
RMTI
$1.10
-$0.03-2.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -12.89% | 9.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.89% | 9.62% | |||
| Cost of Revenue | -4.72% | 3.74% | |||
| Gross Profit | -41.80% | 37.12% | |||
| SG&A Expenses | -3.58% | 6.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.53% | 4.20% | |||
| Operating Income | -126.81% | 275.92% | |||
| Income Before Tax | -145.43% | 385.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -145.43% | 385.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -145.43% | 385.13% | |||
| EBIT | -126.81% | 275.92% | |||
| EBITDA | -99.03% | 132.99% | |||
| EPS Basic | -168.28% | 382.98% | |||
| Normalized Basic EPS | -144.85% | 450.00% | |||
| EPS Diluted | -183.00% | 325.53% | |||
| Normalized Diluted EPS | -146.11% | 463.16% | |||
| Average Basic Shares Outstanding | 4.20% | 3.61% | |||
| Average Diluted Shares Outstanding | 1.41% | 1.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||